| UDI-DI | D-71207-3-EU4Z |
|---|---|
| Secondary DI | |
| Nr katalogowy | 71207-3-EU |
| Status rynkowy | Na rynku UE |
| Pierwsze wprowadzenie | Holandia |
| Wersja EUDAMED | 1 |
| Rodzaj (EMDN) | REAGENTS › IMMUNOCHEMISTRY (IMMUNOLOGY) › DRUGS OF ABUSE / TOXICOLOGY › DRUGS OF ABUSE › AMPHETAMINES GROUP; REAGENTS › IMMUNOCHEMISTRY (IMMUNOLOGY) › DRUGS OF ABUSE / TOXICOLOGY › DRUGS OF ABUSE › BENZODIAZEPINES; REAGENTS › IMMUNOCHEMISTRY (IMMUNOLOGY) › DRUGS OF ABUSE / TOXICOLOGY › DRUGS OF ABUSE › CANNABINOIDS; REAGENTS › IMMUNOCHEMISTRY (IMMUNOLOGY) › DRUGS OF ABUSE / TOXICOLOGY › DRUGS OF ABUSE › COCAINE + COCAINE METABOLITES; REAGENTS › IMMUNOCHEMISTRY (IMMUNOLOGY) › DRUGS OF ABUSE / TOXICOLOGY › DRUGS OF ABUSE › OPIATES; REAGENTS › IMMUNOCHEMISTRY (IMMUNOLOGY) › DRUGS OF ABUSE / TOXICOLOGY › TOXICOLOGY › TRICYCLIC ANTIDEPRESSANTS (TOTAL); REAGENTS › IMMUNOCHEMISTRY (IMMUNOLOGY) › DRUGS OF ABUSE / TOXICOLOGY › TOXICOLOGY › ETHYL GLUCURONIDE; REAGENTS › IMMUNOCHEMISTRY (IMMUNOLOGY) › DRUGS OF ABUSE / TOXICOLOGY › TOXICOLOGY › TOXICOLOGY - OTHER |
| Kody EMDN | W0102090101 AMPHETAMINES GROUP W0102090104 BENZODIAZEPINES W0102090105 CANNABINOIDS W0102090106 COCAINE + COCAINE METABOLITES W0102090113 OPIATES W0102090215 TRICYCLIC ANTIDEPRESSANTS (TOTAL) W0102090220 ETHYL GLUCURONIDE W0102090299 TOXICOLOGY - OTHER |
DrugCheck NxScan OnSite Drug Test AMP BZO COC EtG K2 K3 K4 KET MCAT MPD OPI300 THC & CR NI GL
CareHealth America Corporation · US-MF-000025798
| Basic UDI-DI | B-71207-3-EU4Z |
|---|---|
| Nazwa wyrobu | DrugCheck NxScan OnSite Drug Test - AMP BZO COC EtG K2 K3 K4 KET MCAT MPD OPI300 THC & CR NI GL |
| Model | 71207-3-EU |
| Klasa ryzyka | IVD, kwestie ogólne |
| Podstawa prawna | IVDD (legacy) |
| Typ | odczynnik, POCT |
| Użytek profesjonalny | tak |
Brak Danych dodatkowych – dane z backendu interfejsu EUDAMED nie zostały jeszcze pobrane.